Molecular Partners AG (MOLN) Earnings Date & Reports
Molecular Partners AG is a clinical stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
MOLN is expected to report earnings to fall 7.82% to -49 cents per share on August 25
Q2'25
Est.
$-0.50
Q1'25
Missed
by $0.12
Q4'24
Beat
by $0.33
Q3'24
Beat
by $0.07
Q4'22
Beat
by $4.20
The last earnings report on May 15 showed earnings per share of -54 cents, missing the estimate of -42 cents. With 381.00 shares outstanding, the current market capitalization sits at 134.53M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MOLN showed earnings on May 15, 2025. You can read more about the earnings report here.